Literature DB >> 20211626

Detection of antibodies to Kaposi's sarcoma-associated herpesvirus: a new approach using K8.1 ELISA and a newly developed recombinant LANA ELISA.

Georgina L Mbisa1, Wendell Miley, Christine J Gamache, William K Gillette, Dominic Esposito, Ralph Hopkins, Michael P Busch, George B Schreiber, Richard F Little, Robert Yarchoan, Betty A Ortiz-Conde, Nazzarena Labò, Denise Whitby.   

Abstract

Detection of antibodies to Kaposi's sarcoma-associated herpesvirus (KSHV or Human herpesvirus 8) is a topic of ongoing controversy. KSHV expresses multiple antigens and host responses are highly variable. We have previously described an algorithm for determining KSHV infection based on K8.1 ELISA and LANA immunofluorescence assay (IFA). Here we describe the development of a recombinant ELISA for LANA and an improved testing strategy using ELISAs for LANA and K8.1. We assessed mammalian and baculovirus expression systems for the production of full-length recombinant LANA. We evaluated the performance of LANA ELISAs using human serum samples from several sources including blood donors and clinical patients diagnosed with Kaposi's sarcoma and compared them to LANA IFA. Both LANA ELISAs exhibited comparable sensitivity and specificity to LANA IFA but showed considerably greater reliability. The LANA ELISA can thus be used in conjunction with the previously described K8.1 ELISA to enable the highly sensitive and specific detection of antibodies to KSHV. Use of this testing strategy will provide a more accurate and reliable diagnostic assessment of KSHV status. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20211626      PMCID: PMC2981141          DOI: 10.1016/j.jim.2010.02.015

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  27 in total

1.  Identifying human herpesvirus 8 infection: performance characteristics of serologic assays.

Authors:  E A Engels; D Whitby; P B Goebel; A Stossel; D Waters; A Pintus; L Contu; R J Biggar; J J Goedert
Journal:  J Acquir Immune Defic Syndr       Date:  2000-04-01       Impact factor: 3.731

2.  Latent class analysis of human herpesvirus 8 assay performance and infection prevalence in sub-saharan Africa and Malta.

Authors:  E A Engels; M D Sinclair; R J Biggar; D Whitby; P Ebbesen; J J Goedert; J L Gastwirth
Journal:  Int J Cancer       Date:  2000-12-15       Impact factor: 7.396

3.  Highly sensitive assay for human herpesvirus 8 antibodies that uses a multiple antigenic peptide derived from open reading frame K8.1.

Authors:  Lee L Lam; Chou-Pong Pau; Sheila C Dollard; Philip E Pellett; Thomas J Spira
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

4.  Prevalence of Kaposi's sarcoma-associated herpesvirus infection in sex workers and women from the general population in Spain.

Authors:  Sílvia de Sanjosé; Vickie Marshall; Judit Solà; Virgilio Palacio; Rosa Almirall; James J Goedert; F Xavier Bosch; Denise Whitby
Journal:  Int J Cancer       Date:  2002-03-01       Impact factor: 7.396

5.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

Authors:  E Cesarman; Y Chang; P S Moore; J W Said; D M Knowles
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

6.  Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors.

Authors:  P E Pellett; D J Wright; E A Engels; D V Ablashi; S C Dollard; B Forghani; S A Glynn; J J Goedert; F J Jenkins; T-H Lee; F Neipel; D S Todd; D Whitby; G J Nemo; M P Busch
Journal:  Transfusion       Date:  2003-09       Impact factor: 3.157

7.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

Authors:  Y Chang; E Cesarman; M S Pessin; F Lee; J Culpepper; D M Knowles; P S Moore
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

8.  Development of an immunofluorescence assay using recombinant proteins expressed in insect cells to screen and confirm presence of human herpesvirus 8-specific antibodies.

Authors:  Veenu Minhas; Lynsey N Crosby; Kay L Crabtree; Saul Phiri; Tendai J M'soka; Chipepo Kankasa; William J Harrington; Charles D Mitchell; Charles Wood
Journal:  Clin Vaccine Immunol       Date:  2008-05-28

9.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.

Authors:  J Soulier; L Grollet; E Oksenhendler; P Cacoub; D Cazals-Hatem; P Babinet; M F d'Agay; J P Clauvel; M Raphael; L Degos
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

10.  Antibody reactivity to latent and lytic antigens to human herpesvirus-8 in longitudinally followed homosexual men.

Authors:  Robert J Biggar; Eric A Engels; Denise Whitby; Dean H Kedes; James J Goedert
Journal:  J Infect Dis       Date:  2002-12-13       Impact factor: 5.226

View more
  39 in total

1.  Induction of hyaluronan production by oncogenic KSHV and the contribution to viral pathogenesis in AIDS patients.

Authors:  Lu Dai; Yihan Chen; Karlie Bonstaff; Lisa Doyle; Bryan Toole; Chris Parsons; Zhiqiang Qin
Journal:  Cancer Lett       Date:  2015-03-30       Impact factor: 8.679

2.  Risk Factors for Kaposi's Sarcoma-Associated Herpesvirus DNA in Blood and in Saliva in Rural Uganda.

Authors:  Angela Nalwoga; Marjorie Nakibuule; Vickie Marshall; Wendell Miley; Nazzarena Labo; Stephen Cose; Denise Whitby; Robert Newton
Journal:  Clin Infect Dis       Date:  2020-08-14       Impact factor: 9.079

3.  Relationship between human leukocyte antigen alleles and risk of Kaposi's sarcoma in Cameroon.

Authors:  Elena M Cornejo Castro; Brian J Morrison; Vickie A Marshall; Nazzarena Labo; Wendell J Miley; Nathan Clements; George Nelson; Paul Ndom; Kristen Stolka; Jennifer J Hemingway-Foday; Mahamat Abassora; Xiaojiang Gao; Jennifer S Smith; Mary Carrington; Denise Whitby
Journal:  Genes Immun       Date:  2019-05-20       Impact factor: 2.676

Review 4.  Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.

Authors:  Thomas S Uldrick; Denise Whitby
Journal:  Cancer Lett       Date:  2011-03-04       Impact factor: 8.679

Review 5.  Serodiagnosis for tumor viruses.

Authors:  Brian J Morrison; Nazzarena Labo; Wendell J Miley; Denise Whitby
Journal:  Semin Oncol       Date:  2014-12-31       Impact factor: 4.929

6.  Quantitative determinations of anti-Kaposi sarcoma-associated herpesvirus antibody levels in men who have sex with men.

Authors:  Emile Gogineni; Vickie Marshall; Wendell Miley; Ahmad Bayat; Denise Whitby; Joseph A Kovacs; Peter D Burbelo
Journal:  Diagn Microbiol Infect Dis       Date:  2013-03-28       Impact factor: 2.803

7.  Risk factors for Kaposi's sarcoma among HIV-positive individuals in a case control study in Cameroon.

Authors:  Kristen Stolka; Paul Ndom; Jennifer Hemingway-Foday; Jeniffer Iriondo-Perez; Wendell Miley; Nazzarena Labo; Jennifer Stella; Mahamat Abassora; Godfrey Woelk; Robin Ryder; Denise Whitby; Jennifer S Smith
Journal:  Cancer Epidemiol       Date:  2014-03-13       Impact factor: 2.984

8.  Kaposi Sarcoma-Associated Herpesvirus and Staphylococcus aureus Coinfection in Oral Cavities of HIV-Positive Patients: A Unique Niche for Oncogenic Virus Lytic Reactivation.

Authors:  Lu Dai; Jing Qiao; Jun Yin; Alana Goldstein; Hui-Yi Lin; Steven R Post; Zhiqiang Qin
Journal:  J Infect Dis       Date:  2020-03-28       Impact factor: 5.226

9.  Kaposi sarcoma-associated herpes virus and response to antiretroviral therapy: a prospective study of HIV-infected adults.

Authors:  Mhairi Maskew; A Patrick MacPhail; Denise Whitby; Matthias Egger; Matthew P Fox
Journal:  J Acquir Immune Defic Syndr       Date:  2013-08-01       Impact factor: 3.731

10.  Kaposi's Sarcoma Associated-Herpes Virus (KSHV) Seroprevalence in Pregnant Women in South Africa.

Authors:  Babatyi I Malope-Kgokong; Patrick Macphail; Georgina Mbisa; Edith Ratshikhopha; Mhairi Maskew; Lara Stein; Freddy Sitas; Denise Whitby
Journal:  Infect Agent Cancer       Date:  2010-08-31       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.